Clinilabs invites you to their event

Research Methods in Clinical Neuropsychiatry: Focus on POC (Phase 2) and Pivotal (Phase 3) trials

About this event

This session will cover basic research methods including parallel group, crossover, double-blind, single-blind, and open-label designs. Other methodology basics such as randomization, placebo controls, placebo run-ins will be covered.

Hosted by

  • Team member
    T
    Gary Zammit President & CEO @ Clinilabs Drug Development Corporation

    Gary Zammit is a neuroscientist and sleep specialist who founded Clinilabs Drug Development Corporation in 2001. He is widely recognized as a key opinion leader in the field of sleep medicine, and has been involved in the development of new drugs to treat sleep disorders such as narcolepsy, insomnia, excessive sleepiness, and circadian rhythm disorders.

Clinilabs

The CRO for CNS

We are a global, full-service contract research organization (CRO), the only one focused exclusively on central nervous system (CNS) drug development. We are dedicated to bringing new therapies to patients living with mental health, neurological and substance abuse disorders.